https://stock.noler.com/us/stock/map-pharmaceuticals-inc https://stock.noler.com/us/stock/map-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/map-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/map-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/map-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/map-pharmaceuticals-inc/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/map-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/map-pharmaceuticals-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/map-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/map-pharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/map-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/map-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/map-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/map-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/map-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/map-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/map-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/map-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/map-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/map-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/map-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/map-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/map-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/map-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/map-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/map-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/map-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/map-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/map-pharmaceuticals-inc/dividends-preferred-stock https://stock.noler.com/us/stock/map-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/map-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/map-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/map-pharmaceuticals-inc/equity-issuance-dollar-amount-per-share https://stock.noler.com/us/stock/map-pharmaceuticals-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/map-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/map-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/map-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/map-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/map-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/map-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/map-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/map-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/map-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/map-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/map-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/map-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/map-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/map-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/map-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/map-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/map-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/map-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/map-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/map-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/map-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/map-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/map-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/map-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/map-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/map-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/map-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/map-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/map-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/map-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/map-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/map-pharmaceuticals-inc/restricted-investments-noncurrent https://stock.noler.com/us/stock/map-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/map-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-issued-for-stock-awards https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/map-pharmaceuticals-inc/shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/map-pharmaceuticals-inc/short-term-debt https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-dividend https://stock.noler.com/us/stock/map-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/map-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/map-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/map-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/map-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted